PepGen, Inc’s (PEPG) IPO went live earlier today. Trading opened at $15.60 per unit after 9,000,000 shares were priced at $12. The shares dropped to $12 since then.

The joint book-running manager for this offering is BofA Securities and SVB Securities. Wedbush PacificGrow acts as the lead-manager of this offering.

PepGen, a biotechnology company in clinical stage that is working to develop the next generation oligonucleotide treatments with the aim of changing the treatment for severe neurological and neuromuscular diseases, is PepGen.